FDA has placed a partial clinical hold on the initiation of new patients in U.S. studies evaluating magrolimab to treat acute myeloid leukemia.
Nearly 80% of NIH staff will be furloughed if Congress fails to fund the federal government or pass a continuing resolution before midnight Saturday, Sept. 30—halting many administrative functions and nonclinical activities in the agency’s research pipelines.
